Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

Background: Immune checkpoint blockade (ICB) has been proved to have significant anti-tumor effect in the clinical treatment of non-small cell lung cancer (NSCLC). Therefore, biomarkers predicting ICB response can provide better treatment for patients with NSCLC. Methods: Differential expression gen...

Full description

Bibliographic Details
Main Authors: Yingqi Xu, Jianlin Xu, Rong Qiao, Hua Zhong, Jinjing Xia, Runbo Zhong
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Translational Oncology
Subjects:
Non-small cell lung cancer (NSCLC)
Immune checkpoint blockade (ICB)
BLK
prognosis
Tumor growth
RNA sequencing
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323000578

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323000578

Similar Items